Bradsaúde S.A. (BVMF:SAUD3)
Brazil · Delayed Price · Currency is BRL 15.01
+0.07 (0.47%)
At close: Jul 29, 2026
Bradsaúde Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 2,406 | 2,380 | 2,243 | 2,084 | 1,847 | 1,923 |
Total Interest & Dividend Income | 121.62 | 125.02 | 133.47 | 126.19 | 88.84 | 54.28 |
Non-Insurance Activities Revenue | 40.87 | 40.18 | 38.19 | 51.56 | 21.89 | 16.41 |
| 2,569 | 2,545 | 2,415 | 2,261 | 1,958 | 1,994 | |
Revenue Growth | 5.10% | 5.41% | 6.78% | 15.50% | -1.79% | 5.91% |
Policy Benefits | 771.07 | 769.46 | 753.57 | 737.85 | 735.47 | 700.38 |
Policy Acquisition & Underwriting Costs | 295.73 | 280.32 | 268.3 | 242.59 | 245.26 | - |
Depreciation & Amortization | - | - | - | 4.32 | 2.07 | 5.82 |
Selling, General & Administrative | 124.38 | 122.37 | 112.44 | 99.28 | 30.71 | 516.53 |
Provision for Bad Debts | - | - | - | 0.9 | 0.88 | 48.92 |
Non-Insurance Activities Expense | 58.93 | 58.52 | 53.63 | - | - | - |
Other Operating Expenses | 453.1 | 422.37 | 412.35 | 370.94 | 347.58 | 123.77 |
Total Operating Expenses | 1,703 | 1,653 | 1,600 | 1,491 | 1,389 | 1,437 |
Operating Income | 865.41 | 892.14 | 814.36 | 770.07 | 568.98 | 556.8 |
Interest Expense | -41.67 | -42.6 | -36.46 | -33.55 | -6.08 | -2.7 |
Earnings From Equity Investments | 5.9 | 5.92 | 6.34 | 4.15 | 6.13 | 6.56 |
Other Non Operating Income (Expenses) | -25.77 | -25.81 | -20.87 | -14.3 | -45.09 | -12.36 |
EBT Excluding Unusual Items | 803.88 | 829.65 | 763.38 | 726.37 | 523.94 | 548.3 |
Gain (Loss) on Sale of Assets | - | - | - | -1.98 | -6.64 | -1.12 |
Pretax Income | 803.88 | 829.65 | 763.38 | 724.39 | 517.29 | 547.18 |
Income Tax Expense | 238.77 | 247.11 | 224.24 | 212.8 | 151.05 | 165.84 |
Earnings From Continuing Ops. | 565.11 | 582.54 | 539.13 | 511.59 | 366.25 | 381.34 |
Minority Interest in Earnings | -0.13 | 0.03 | 0.11 | -0.2 | -0.39 | -0.98 |
Net Income | 564.98 | 582.57 | 539.24 | 511.39 | 365.86 | 380.36 |
Net Income to Common | 564.98 | 582.57 | 539.24 | 511.39 | 365.86 | 380.36 |
Net Income Growth | 0.49% | 8.04% | 5.45% | 39.78% | -3.81% | 5.33% |
Shares Outstanding (Basic) | 545 | 545 | 547 | 552 | 553 | 579 |
Shares Outstanding (Diluted) | 545 | 545 | 547 | 552 | 553 | 580 |
Shares Change | 0.08% | -0.25% | -1.04% | -0.08% | -4.68% | -0.72% |
EPS (Basic) | 1.04 | 1.07 | 0.99 | 0.93 | 0.66 | 0.66 |
EPS (Diluted) | 1.04 | 1.07 | 0.99 | 0.93 | 0.66 | 0.66 |
EPS Growth | 0.41% | 8.31% | 6.55% | 39.89% | 0.91% | 6.08% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 548.21 | 583.81 | 531.15 | 406.96 | 686.19 | 852.87 |
Free Cash Flow Per Share | 1.01 | 1.07 | 0.97 | 0.74 | 1.24 | 1.47 |
Dividend Per Share | 0.559 | 0.814 | 0.817 | 0.928 | 0.433 | 0.327 |
Dividend Growth | -40.51% | -0.44% | -11.91% | 114.42% | 32.52% | -42.83% |
Operating Margin | 33.69% | 35.05% | 33.73% | 34.05% | 29.06% | 27.93% |
Profit Margin | 22.00% | 22.89% | 22.33% | 22.61% | 18.68% | 19.08% |
Free Cash Flow Margin | 21.34% | 22.94% | 22.00% | 18.00% | 35.04% | 42.78% |
EBITDA | 862.58 | 902.16 | 870.51 | 819.3 | 601.37 | 614.56 |
EBITDA Margin | 33.58% | 35.45% | 36.05% | 36.23% | 30.71% | 30.82% |
D&A For EBITDA | -2.82 | 10.02 | 56.15 | 49.23 | 32.4 | 57.76 |
EBIT | 865.41 | 892.14 | 814.36 | 770.07 | 568.98 | 556.8 |
EBIT Margin | 33.69% | 35.05% | 33.73% | 34.05% | 29.06% | 27.93% |
Effective Tax Rate | 29.70% | 29.79% | 29.38% | 29.38% | 29.20% | 30.31% |